Report #2877282

Received Dec 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 1.5 yrs
State: NV
Recovered: Unknown
Vaccinated: Dec 4, 2025
Onset: Dec 4, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Second dose given 5 days early; This non-serious case was reported by a other health professional via sales rep and described the occurrence of drug dose administration interval too short in a 18-month-old male patient who received HAV (Havrix 720 Junior) for prophylaxis. Previously administered products included Havrix 720 (1st dose taken on 09-JUN-2025). On 04-DEC-2025, the patient received the 2nd dose of Havrix 720 Junior. On 04-DEC-2025, an unknown time after receiving Havrix 720 Junior, the patient experienced drug dose administration interval too short (Verbatim: Second dose given 5 days early). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK receipt date 04-DEC-2025 The batch number was not provided and a request for this information has been made.